Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Harold Litt, MD

Harold Litt named new editor of RSNA's cardiothoracic imaging journal

Litt, a leading name in the fields of radiology and cardiology, has been with the journal since it was first launched in 2019. 

 

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Bayer's new imaging agent for cardiac amyloidosis impresses in clinical trial

The REVEAL study has been assessing the sensitivity and specificity of iodine 124 evuzamitide (I 124 evuzamitide), a PET agent capable of visualizing signs of cardiac amyloidosis on imaging.

doctor wrong patient wrong-site surgery medical error malpractice mistake

FDA announces more recalls due to risk of syringe breaking during treatment

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.

CCTA characterization of a chronic total occlusion with angiographic correlation during percutaneous coronary intervention.

CCTA brings clarity, better outcomes to CTO PCI

Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.

Heartflow Video

Physicians chime in: Coronary plaque staging offers more precise cardiac patient management

Sponsored by Heartflow

As precision cardiology continues to evolve, the integration of advanced coronary computed tomography angiography (CCTA) and AI-driven analysis is fundamentally changing how we assess and manage coronary artery disease (CAD). Here is a closer look at how Heartflow Plaque Staging is leveraging Total Plaque Volume (TPV) to stratify patient risk.

Society of cardiovascular computed tomography (SCCT) President Kavitha Chinnaiyan, MD, FACC, MSCCT, a cardiologist and professor of medicine at Oakland University William Beaumont School of Medicine in Royal Oak, with is part of Corewell Health, explains some of the key trends in coronary computed tomography angiography (CCTA) and how this is being translated into educational programming at the SCCT 2026 annual scientific meeting (ASM). #SCCT2026

SCCT President: Key trends in cardiac CT

As CCTA sees rapid adoption across cardiology, SCCT is working to address the education required to sustain the expansion.

Kimberly Hatch, RT(R)(CT)(ARRT), technical director of 3D lab at Banner Health, explains the advances in advanced visualization software what is needed to build a comprehensive cardiac 3D imaging lab.

Leveraging IT and AI to transform 3D imaging lab workflows at Banner Health

Procedure planning studies that once took hours can now be completed in just 25 minutes with 3D technology advances and AI.

Kimberly Hatch, RT(R)(CT)(ARRT), technical director of 3D lab at Banner Health, explains the advances in advanced visualization software what is needed to build a comprehensive cardiac 3D imaging lab.

Advanced AI helps 3D imaging labs evolve with the times

“Technology grows and grows,” as one lab director explained. “Our job is to keep up with it and use it in the most efficient and effective way.”